Mr. Lee has been a member of our Board of Directors since March 2018. Since January 2003, he has been a general partner of Hatteras Venture Partners, LLC, a venture capital fund focusing on life science companies. Previously he was president of Pappas Capital, LLC (formerly A. M. Pappas & Associates, LLC), following 29 years with Ernst & Young LLP, where he was most recently managing director of the firm’s health sciences corporate finance group. Mr. Lee currently serves on the board of directors of BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX). Previously, he served on the boards of several private and public companies, including Abgenix, Inc. (NASDAQ: ABGX, acquired by Amgen Inc. (NASDAQ: AMGN)), CV Therapeutics, Inc. (NASDAQ: CVTX, acquired by Gilead Sciences, Inc. (NASDAQ: GILD)), Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH, acquired by Merck & Co., Inc. NYSE: MRK), Maxygen, Inc. (NASDAQ: MAXY, dissolved), OSI Pharmaceuticals, Inc. (NASDAQ: OSIP, acquired by Astellas Pharma Inc. (OTC: ALPMY)), Old API Wind-down Ltd. (f/k/a Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ), which began voluntary bankruptcy proceedings in Canada and filed for Chapter 11 bankruptcy in the United States in August 2018). Mr. Lee received a B.A. from Lenoir-Rhyne College and an M.B.A. from the University of North Carolina at Chapel Hill.
What is Kenneth B. Lee, Jr.'s net worth?
The estimated net worth of Kenneth B. Lee, Jr. is at least $973.56 as of June 14th, 2021. Mr. Lee, Jr. owns 266 shares of Hyperion DeFi stock worth more than $974 as of December 19th. This net worth estimate does not reflect any other assets that Mr. Lee, Jr. may own. Learn More about Kenneth B. Lee, Jr.'s net worth.
How do I contact Kenneth B. Lee, Jr.?
Has Kenneth B. Lee, Jr. been buying or selling shares of Hyperion DeFi?
Kenneth B. Lee, Jr. has not been actively trading shares of Hyperion DeFi within the last three months. Most recently, on Monday, June 14th, Kenneth B. Lee, Jr. bought 25 shares of Hyperion DeFi stock. The stock was acquired at an average cost of $437.60 per share, with a total value of $10,940.00. Following the completion of the transaction, the director now directly owns 266 shares of the company's stock, valued at $116,401.60. Learn More on Kenneth B. Lee, Jr.'s trading history.
Who are Hyperion DeFi's active insiders?
Are insiders buying or selling shares of Hyperion DeFi?
In the last twelve months, Hyperion DeFi insiders bought shares 1 times. They purchased a total of 30,000 shares worth more than $90,300.00. The most recent insider tranaction occured on December, 17th when Director Michael S Geltzeiler bought 30,000 shares worth more than $90,300.00. Insiders at Hyperion DeFi own 10.9% of the company.
Learn More about insider trades at Hyperion DeFi. Information on this page was last updated on 12/17/2025.
